SHANGHAI - Global biopharmaceutical company Bristol-Myers Squibb has called a media buying pitch in China.
It is understood that several undisclosed agencies have already been shortlisted for the business. Agencies are now are waiting for a brief and pitch date.
The incumbent agency on the account is Mindshare.
The pitch is for Bristol-Myers Squibb's over the counter medicines, including its vitamins.
Earlier this month, Bristol-Meyers Squibb agreed a new collaboration with Simcere Pharmaceutical Group, a China-based company, to jointly develop a new cancer treatment.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
With bold campaigns, record-breaking new business wins, and a near-perfect client retention rate, the agency proved it could lead from the front. Yet, challenges in China and the pressures of rapid growth loom large—testing whether its ‘disruption’ can stand the test of time.
As the advertising landscape shifts and job security wanes, a growing number of ad professionals are reinventing themselves as creators to stay relevant and stand out.
The in-house taps retro classic folk songs to bring enduring real world trades into the digital age.
.png&h=268&w=401&q=100&v=20250320&c=1)
The US Federal Trade Commission approved Omnicom’s $13.5 billion acquisition of Interpublic, with restrictions against coordinating ad spending based on political or ideological content.
.jpg&h=334&w=500&q=100&v=20250320&c=1)
.png&h=334&w=500&q=100&v=20250320&c=1)
.png&h=334&w=500&q=100&v=20250320&c=1)
.png&h=334&w=500&q=100&v=20250320&c=1)
.jpg&h=268&w=401&q=100&v=20250320&c=1)
